Diabetes and Weight Management Part 1-Weight Management Treatment Infographic

Weight Management Treatment Infographic
Pdf Summary
This infographic, based on the American Diabetes Association’s (ADA) Standards of Care in Diabetes—2023, details the treatment options for weight management, particularly for individuals with Type 2 Diabetes. Recommendations for effective weight management include both surgical and pharmacological approaches, coupled with lifestyle modifications and personalized goal-setting strategies.<br /><br />**Behavioral Strategies and Goal-Setting**<br />- Behavioral strategies are crucial to support diabetes self-management and health behavior engagement.<br />- Goals should be SMART: Specific, Measurable, Actionable, Realistic, and Timely.<br /><br />**Surgical Treatment**<br />- Bariatric surgery is one of the surgical options available for weight management in diabetics.<br /><br />**Pharmacological Agents**<br />1. **Orlistat (Lipase inhibitor)**<br />   - Side effects: Abdominal pain, flatulence, fecal urgency.<br />   - Safety concerns: Possible malabsorption of fat-soluble vitamins and certain medications, rare severe liver injury, cholelithiasis, and nephrolithiasis.<br />   <br />2. **Phentermine (Sympathomimetic amine anorectic - short-term treatment)**<br />   - Side effects: Dry mouth, insomnia, dizziness, irritability, increased blood pressure, elevated heart rate.<br />   - Safety concerns: Contraindicated with monoamine oxidase inhibitors (MAOIs).<br /><br />3. **Phentermine/Topiramate ER (Sympathomimetic amine anorectic/antiepileptic combination)**<br />   - Side effects: Constipation, paresthesia, insomnia, nasopharyngitis, xerostomia, increased blood pressure.<br />   - Safety concerns: Birth defects, cognitive impairment, acute angle-closure glaucoma, MAOI contraindication.<br />   <br />4. **Naltrexone/Bupropion ER (Opioid antagonist/antidepressant combination - long-term treatment)**<br />   - Side effects: Constipation, nausea, headache, xerostomia, insomnia, elevated heart rate, and blood pressure.<br />   - Safety concerns: Contraindicated in unmanaged hypertension, seizure disorders, chronic opioid therapy, risk of suicidal behavior/ideation (Black Box Warning).<br /><br />5. **Liraglutide and Semaglutide (Glucagon-like peptide 1 receptor agonists)**<br />   - Side effects: Gastrointestinal issues, injection site reactions, elevated heart rate, hypoglycemia.<br />   - Safety concerns: Pancreatitis risk, kidney injury, cholelithiasis, gallstone-related complications, thyroid C-cell tumors risk in rodents (Black Box Warning).<br /><br />For more detailed information on obesity pharmacotherapy, refer to Section 8 of the ADA’s Standards of Care in Diabetes—2023, and visit diabetes.org or call 1-800-DIABETES.
Keywords
Type 2 Diabetes
Weight Management
Behavioral Strategies
Bariatric Surgery
Pharmacological Agents
Orlistat
Phentermine
Naltrexone/Bupropion
Liraglutide
Semaglutide